{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:58:21Z","timestamp":1789624701351,"version":"build-2803163510"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Deregulation of Ras pathways results in complex abnormalities of multiple signaling cascades that contribute to human malignancies. Ras is therefore considered an appropriate target for cancer therapy. In light of the complexity of the deregulated Ras pathway, it is important to decipher at the molecular level the response of cancer cells to Ras inhibitors that would reregulate it. In the present study, we used gene expression profiling as a robust method for the global dissection of gene expression alterations that resulted from treatment with the Ras inhibitor S-farnesylthiosalicylic acid (FTS; salirasib). Use of a ranking-based procedure, combined with functional analysis and promoter sequence analysis, enabled us to decipher the common and most prominent patterns of the transcriptional response of five different human cancer cell lines to FTS. Remarkably, the analysis identified a distinctive core transcriptional response to FTS that was common to all cancer cell lines tested. This signature fits well to a recently described deregulated Ras pathway signature that predicted sensitivity to FTS. Taken together, these studies provide strong support for the conclusion that FTS specifically reregulates defective Ras pathways in human tumor cells. Ras pathway reregulation by FTS was manifested by repression of E2F-regulated and NF-Y\u2013regulated genes and of the transcription factor FOS (all of which control cell proliferation), repression of survivin expression (which blocks apoptosis), and induction of activating transcription factor\u2013regulated and Bach2-regulated genes (which participate in translation and stress responses). Our results suggest that cancer patients with deregulated Ras pathway tumors might benefit from FTS treatment. [Cancer Res 2007;67(7):3320\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4287","type":"journal-article","created":{"date-parts":[[2007,4,4]],"date-time":"2007-04-04T20:32:35Z","timestamp":1175718755000},"page":"3320-3328","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Gene Expression Signature of Human Cancer Cell Lines Treated with the Ras Inhibitor Salirasib (\n                    <i>S<\/i>\n                    -Farnesylthiosalicylic Acid)"],"prefix":"10.1158","volume":"67","author":[{"given":"Roy","family":"Blum","sequence":"first","affiliation":[{"name":"1Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Elkon","sequence":"additional","affiliation":[{"name":"2David and Inez Myers Laboratory for Genetic Research, Department of Human Genetics, Sackler Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Yaari","sequence":"additional","affiliation":[{"name":"1Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Zundelevich","sequence":"additional","affiliation":[{"name":"1Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Jacob-Hirsch","sequence":"additional","affiliation":[{"name":"3Sheba Cancer Research Center and Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Sheba Medical Center and Sackler Faculty of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Rechavi","sequence":"additional","affiliation":[{"name":"1Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences,"},{"name":"3Sheba Cancer Research Center and Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Sheba Medical Center and Sackler Faculty of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Shamir","sequence":"additional","affiliation":[{"name":"4School of Computer Science, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[{"name":"1Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,4,4]]},"reference":[{"key":"2022061623232968700_B1","doi-asserted-by":"crossref","unstructured":"Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer\u20082003; 3: 11\u201322.","DOI":"10.1038\/nrc969"},{"key":"2022061623232968700_B2","doi-asserted-by":"crossref","unstructured":"Cox AD, Der CJ. Farnesyltransferase inhibitors: promises and realities. Curr Opin Pharmacol\u20082002; 2: 388\u201393.","DOI":"10.1016\/S1471-4892(02)00181-9"},{"key":"2022061623232968700_B3","doi-asserted-by":"crossref","unstructured":"Blum R, Kloog Y. Tailoring Ras-pathway-inhibitor combinations for cancer therapy. Drug Resist Updat\u20082005; 8: 369\u201380.","DOI":"10.1016\/j.drup.2005.11.002"},{"key":"2022061623232968700_B4","doi-asserted-by":"crossref","unstructured":"Kloog Y, Cox AD. RAS inhibitors: potential for cancer therapeutics. Mol Med Today\u20082000; 6: 398\u2013402.","DOI":"10.1016\/S1357-4310(00)01789-5"},{"key":"2022061623232968700_B5","doi-asserted-by":"crossref","unstructured":"Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G, Kloog Y. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1\u03b1, causing glycolysis shutdown and cell death. Cancer Res\u20082005; 65: 999\u20131006.","DOI":"10.1158\/0008-5472.999.65.3"},{"key":"2022061623232968700_B6","doi-asserted-by":"crossref","unstructured":"Yaari S, Jacob-Hirsch J, Amariglio N, et al. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Clin Cancer Res\u20082005; 11: 4321\u201330.","DOI":"10.1158\/1078-0432.CCR-04-2071"},{"key":"2022061623232968700_B7","doi-asserted-by":"crossref","unstructured":"Santen RJ, Lynch AR, Neal LR, McPherson RA, Yue W. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells. Anticancer Drugs\u20082006; 17: 33\u201340.","DOI":"10.1097\/01.cad.0000185184.64980.39"},{"key":"2022061623232968700_B8","doi-asserted-by":"crossref","unstructured":"Halaschek-Wiener J, Wacheck V, Kloog Y, Jansen B. Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells. Cell Signal\u20082004; 16: 1319\u201327.","DOI":"10.1016\/j.cellsig.2004.04.003"},{"key":"2022061623232968700_B9","doi-asserted-by":"crossref","unstructured":"Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature\u20082006; 439: 353\u20137.","DOI":"10.1038\/nature04296"},{"key":"2022061623232968700_B10","doi-asserted-by":"crossref","unstructured":"Segal E, Friedman N, Koller D, Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet\u20082004; 36: 1090\u20138.","DOI":"10.1038\/ng1434"},{"key":"2022061623232968700_B11","doi-asserted-by":"crossref","unstructured":"Potti A, Dressman HK, Bild A, et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med\u20082006; 12: 1294\u2013300.","DOI":"10.1038\/nm1491"},{"key":"2022061623232968700_B12","doi-asserted-by":"crossref","unstructured":"Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem\u20082002; 277: 11617\u201320.","DOI":"10.1074\/jbc.R100063200"},{"key":"2022061623232968700_B13","doi-asserted-by":"crossref","unstructured":"Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res\u20082003; 13: 773\u201380.","DOI":"10.1101\/gr.947203"},{"key":"2022061623232968700_B14","doi-asserted-by":"crossref","unstructured":"Shamir R, Maron-Katz A, Tanay A, et al. EXPANDER\u2014an integrative program suite for microarray data analysis. BMC Bioinformatics\u20082005; 6: 232.","DOI":"10.1186\/1471-2105-6-232"},{"key":"2022061623232968700_B15","unstructured":"Sharan R, Shamir R. CLICK: a clustering algorithm with applications to gene expression analysis. Proc Int Conf Intell Syst Mol Biol\u20082000; 8: 307\u201316."},{"key":"2022061623232968700_B16","doi-asserted-by":"crossref","unstructured":"Blum R, Jacob-Hirsch J, Rechavi G, Kloog Y. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis. Mol Cancer Ther\u20082006; 5: 2337\u201347.","DOI":"10.1158\/1535-7163.MCT-06-0193"},{"key":"2022061623232968700_B17","doi-asserted-by":"crossref","unstructured":"Tong T, Ji J, Jin S, et al. Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. Mol Cell Biol\u20082005; 25: 4488\u2013500.","DOI":"10.1128\/MCB.25.11.4488-4500.2005"},{"key":"2022061623232968700_B18","doi-asserted-by":"crossref","unstructured":"Blais JD, Filipenko V, Bi M, et al. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol\u20082004; 24: 7469\u201382.","DOI":"10.1128\/MCB.24.17.7469-7482.2004"},{"key":"2022061623232968700_B19","doi-asserted-by":"crossref","unstructured":"Yoon SO, Shin S, Mercurio AM. Ras stimulation of E2F activity and a consequent E2F regulation of integrin \u03b16\u03b24 promote the invasion of breast carcinoma cells. Cancer Res\u20082006; 66: 6288\u201395.","DOI":"10.1158\/0008-5472.CAN-06-0826"},{"key":"2022061623232968700_B20","doi-asserted-by":"crossref","unstructured":"Berkovich E, Ginsberg D. Ras induces elevation of E2F-1 mRNA levels. J Biol Chem\u20082001; 276: 42851\u20136.","DOI":"10.1074\/jbc.M103596200"},{"key":"2022061623232968700_B21","doi-asserted-by":"crossref","unstructured":"Gu Z, Kuntz-Simon G, Rommelaere J, Cornelis J. Oncogenic transformation-dependent expression of a transcription factor NF-Y subunit. Mol Carcinog\u20081999; 24: 294\u20139.","DOI":"10.1002\/(SICI)1098-2744(199904)24:4<294::AID-MC7>3.0.CO;2-Q"},{"key":"2022061623232968700_B22","doi-asserted-by":"crossref","unstructured":"Pruitt K, Pestell RG, Der CJ. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. J Biol Chem\u20082000; 275: 40916\u201324.","DOI":"10.1074\/jbc.M006682200"},{"key":"2022061623232968700_B23","doi-asserted-by":"crossref","unstructured":"Johnson DG, Cress WD, Jakoi L, Nevins JR. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A\u20081994; 91: 12823\u20137.","DOI":"10.1073\/pnas.91.26.12823"},{"key":"2022061623232968700_B24","doi-asserted-by":"crossref","unstructured":"Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1\/S and G2\/M transcription. EMBO J\u20082004; 23: 4615\u201326.","DOI":"10.1038\/sj.emboj.7600459"},{"key":"2022061623232968700_B25","doi-asserted-by":"crossref","unstructured":"Salsi V, Caretti G, Wasner M, et al. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J Biol Chem\u20082003; 278: 6642\u201350.","DOI":"10.1074\/jbc.M210065200"},{"key":"2022061623232968700_B26","doi-asserted-by":"crossref","unstructured":"Fan J, Bertino JR. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene\u20081997; 14: 2595\u2013607.","DOI":"10.1038\/sj.onc.1201105"},{"key":"2022061623232968700_B27","unstructured":"Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. ATF3 and stress responses. Gene Expr\u20081999; 7: 321\u201335."},{"key":"2022061623232968700_B28","doi-asserted-by":"crossref","unstructured":"Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38\/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia\/reperfusion. Circ Res\u20081996; 79: 162\u201373.","DOI":"10.1161\/01.RES.79.2.162"},{"key":"2022061623232968700_B29","doi-asserted-by":"crossref","unstructured":"Rhodes DR, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A\u20082004; 101: 9309\u201314.","DOI":"10.1073\/pnas.0401994101"},{"key":"2022061623232968700_B30","doi-asserted-by":"crossref","unstructured":"Liang Y, Diehn M, Watson N, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A\u20082005; 102: 5814\u20139.","DOI":"10.1073\/pnas.0402870102"},{"key":"2022061623232968700_B31","doi-asserted-by":"crossref","unstructured":"Sharan R, Maron-Katz A, Shamir R. CLICK and EXPANDER: a system for clustering and visualizing gene expression data. Bioinformatics\u20082003; 19: 1787\u201399.","DOI":"10.1093\/bioinformatics\/btg232"},{"key":"2022061623232968700_B32","doi-asserted-by":"crossref","unstructured":"Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol\u20081997; 17: 3850\u20137.","DOI":"10.1128\/MCB.17.7.3850"},{"key":"2022061623232968700_B33","doi-asserted-by":"crossref","unstructured":"Alabert C, Rogers L, Kahn L, et al. Cell type-dependent control of NF-Y activity by TGF-\u03b2. Oncogene\u20082006; 25: 3387\u201396.","DOI":"10.1038\/sj.onc.1209385"},{"key":"2022061623232968700_B34","doi-asserted-by":"crossref","unstructured":"Blum R, Nakdimon I, Goldberg L, et al. E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition. Int J Cancer\u20082006; 119: 527\u201338.","DOI":"10.1002\/ijc.21735"},{"key":"2022061623232968700_B35","doi-asserted-by":"crossref","unstructured":"Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta\u20082002; 1576: 1\u201314.","DOI":"10.1016\/S0167-4781(02)00343-3"},{"key":"2022061623232968700_B36","doi-asserted-by":"crossref","unstructured":"Zhang H, Liu H, Iles KE, et al. 4-Hydroxynonenal induces rat \u03b3-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element\/nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol\u20082006; 34: 174\u201381.","DOI":"10.1165\/rcmb.2005-0280OC"},{"key":"2022061623232968700_B37","doi-asserted-by":"crossref","unstructured":"Cam H, Balciunaite E, Blais A, et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell\u20082004; 16: 399\u2013411.","DOI":"10.1016\/j.molcel.2004.09.037"},{"key":"2022061623232968700_B38","doi-asserted-by":"crossref","unstructured":"Harding HP, Novoa I, Zhang Y, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell\u20082000; 6: 1099\u2013108.","DOI":"10.1016\/S1097-2765(00)00108-8"},{"key":"2022061623232968700_B39","doi-asserted-by":"crossref","unstructured":"Novoa I, Zeng H, Harding HP, Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2\u03b1. J Cell Biol\u20082001; 153: 1011\u201322.","DOI":"10.1083\/jcb.153.5.1011"},{"key":"2022061623232968700_B40","doi-asserted-by":"crossref","unstructured":"Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest\u20082002; 110: 1383\u20138.","DOI":"10.1172\/JCI0216784"},{"key":"2022061623232968700_B41","doi-asserted-by":"crossref","unstructured":"Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett\u20081998; 421: 125\u201330.","DOI":"10.1016\/S0014-5793(97)01548-2"},{"key":"2022061623232968700_B42","doi-asserted-by":"crossref","unstructured":"Rosenwald IB. The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene\u20082004; 23: 3230\u201347.","DOI":"10.1038\/sj.onc.1207552"},{"key":"2022061623232968700_B43","unstructured":"Meric F, Hunt KK. Translation initiation in cancer: a novel target for therapy. Mol Cancer Ther\u20082002; 1: 971\u20139."},{"key":"2022061623232968700_B44","doi-asserted-by":"crossref","unstructured":"Park KM, Kim DJ, Paik SG, Kim SJ, Yeom YI. Role of E2F1 in endoplasmic reticulum stress signaling. Mol Cell\u20082006; 21: 356\u20139.","DOI":"10.1016\/S1016-8478(23)12863-9"},{"key":"2022061623232968700_B45","doi-asserted-by":"crossref","unstructured":"Yoshida C, Yoshida F, Sears D, et al. Bcr-Abl signaling through the PI-3\/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the anti-apoptotic factor heme oxygenase-1. Blood\u20082007; 109: 1211\u20139.","DOI":"10.1182\/blood-2005-12-040972"},{"key":"2022061623232968700_B46","doi-asserted-by":"crossref","unstructured":"Vieira SA, Deininger MW, Sorour A, et al. Transcription factor BACH2 is transcriptionally regulated by the BCR\/ABL oncogene. Genes Chromosomes Cancer\u20082001; 32: 353\u201363.","DOI":"10.1002\/gcc.1200"},{"key":"2022061623232968700_B47","doi-asserted-by":"crossref","unstructured":"Muto A, Tashiro S, Tsuchiya H, et al. Activation of Maf\/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies. J Biol Chem\u20082002; 277: 20724\u201333.","DOI":"10.1074\/jbc.M112003200"},{"key":"2022061623232968700_B48","doi-asserted-by":"crossref","unstructured":"Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A\u20082004; 101: 11269\u201374.","DOI":"10.1073\/pnas.0400541101"},{"key":"2022061623232968700_B49","doi-asserted-by":"crossref","unstructured":"Kamio T, Toki T, Kanezaki R, et al. B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs. Blood\u20082003; 102: 3317\u201322.","DOI":"10.1182\/blood-2002-12-3656"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/7\/3320\/2579038\/3320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/7\/3320\/2579038\/3320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:25:16Z","timestamp":1707747916000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/7\/3320\/534082\/Gene-Expression-Signature-of-Human-Cancer-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2007,4,4]]},"published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4287","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370316.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370304.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370307.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370313","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370310","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370313.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370316","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370304","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370310.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370307","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496353.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496353","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,1]]}}}